| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-05 |